Study of ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Coronary Artery Disease
NCT00905294 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2013-06-19
Summary
The purpose of this research is to determine the relationship between proteins and enzymes in the blood and how they work with platelets to form blood clots in patients with coronary artery disease. The investigators hypothesize that the relationship between these factors could potentially be useful in identifying patients at higher risk for heart attacks.
Conditions
Interventions
- OTHER
-
Blood draws
Observational: blood draws only
Sponsors & Collaborators
-
Royal College of Surgeons, Ireland
collaborator OTHER -
University College Cork
lead OTHER
Principal Investigators
-
Noel M. Caplice, M.D, Ph.D. · University College Cork, Ireland
-
Dermot Kenny, M.D. · Royal College Surgeons in Ireland
-
David Foley, M.B. · Beaumont Hospital, Dublin, Ireland
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Ireland
Study Locations
More Related Trials
-
Vorapaxar on Thrombin Generation and Coagulability
NCT03207451 ·Status: COMPLETED ·Phase: PHASE4
-
Platelets Function and Cardiovascular Events in Patients With End Stage Renal Disease
NCT00407368 ·Status: UNKNOWN
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Platelet Drug Trial in Coronary Disease Progression
NCT00000496 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
NCT00508924 ·Status: COMPLETED ·Phase: PHASE2
-
Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery
NCT01174862 ·Status: COMPLETED
-
Warfarin and Antiplatelet Vascular Evaluation
NCT00125671 ·Status: UNKNOWN ·Phase: PHASE3
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
Reversing Ticagrelor's Effects With Fresh Platelets
NCT02201394 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
NCT02226926 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs
NCT04401761 ·Status: COMPLETED
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED
-
Impact of isoQUercetin and Aspirin on Platelet Function
NCT02866448 ·Status: WITHDRAWN ·Phase: NA
-
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
NCT05125276 ·Status: UNKNOWN ·Phase: PHASE4
-
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
NCT03005704 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
NCT02293395 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Aspirin Studied With the AggreGuide
NCT01603966 ·Status: COMPLETED
-
Prospective Real-world Registry Describing Treatment Regimens
NCT03942913 ·Status: UNKNOWN
-
Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation
NCT03746782 ·Status: COMPLETED
-
Pharmacogenomics of Antiplatelet Response
NCT02234427 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of the COBRRA AF Anticoagulant Trial in Healthcare Claims Data
NCT05256797 ·Status: COMPLETED
-
Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
NCT02921126 ·Status: COMPLETED
-
Platelet Reactivity and MES During CEA
NCT01547039 ·Status: UNKNOWN
-
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
NCT03787927 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Antithrombin III in Infectious Disease Caused by COVID-19
NCT04899232 ·Status: TERMINATED ·Phase: PHASE2